anti-UDG Antibody (anti-Uracil-DNA Glycosylase / UNG) — Technical Guide for Research Use

Molecular Background

Uracil-DNA glycosylase (UDG, canonical gene UNG) excises uracil from DNA to initiate base excision repair (BER). Curated gene, transcript, and protein accessions, exon–intron structure, and isoform notes are available from NCBI Gene and RefSeq:

• UNG overview: NCBI Gene (nih.gov)

• RefSeq records: RefSeq (nih.gov)

• Protein features & isoforms: NCBI Protein (nih.gov)

• Conserved domains (glycosylase catalytic core): NCBI CDD (nih.gov)

• Genomic context and regulatory tracks: UCSC Genome Browser (.edu)

UDG recognizes U:G and U:A mispairs, flips the base into its catalytic pocket, and cleaves the N-glycosidic bond, generating an AP site processed by AP endonucleases in BER. Useful primers on BER are compiled on the NLM Bookshelf and Assay Guidance Manual:

• BER chapters / protocols: NLM Bookshelf (nih.gov)

• Assay development best practices: Assay Guidance Manual (nih.gov)

Antigen Design and Epitope Strategy

When generating or selecting an anti-UDG antibody, consider:

• Immunogen region: avoid highly conserved catalytic residues to minimize cross-reactivity with SMUG1, TDG, and MBD4 glycosylases. Domain maps via CDD support epitope selection (CDD, nih.gov).

• Isoforms & localization: UNG1 (mitochondrial N-terminal MLS) vs UNG2 (nuclear) — epitope targeting outside the MLS can capture both forms; consult RefSeq for isoform boundaries (RefSeq, nih.gov).

• Post-translational modifications: check reported phosphorylation sites in curated records (NCBI Protein, nih.gov).

General antibody design primers from academic resources: MIT, Stanford, Harvard, UC Berkeley (.edu).

Applications and Use-Cases

 Western Blot (WB)

• Sample: whole cell lysate, nuclear extract, or mitochondrial fraction (for UNG1).

• Expected apparent MW: ~35–38 kDa (isoform-dependent; confirm with RefSeq).

• Controls: siRNA/CRISPR knockdown, overexpression of tagged UNG, and peptide-blocking control.
  Protocols and gel-transfer fundamentals: UCLA, UCSF, UCSD (.edu).

 Immunofluorescence (IF) / Immunocytochemistry (ICC)

• Fixation: 4% PFA or methanol; optimize for nuclear epitope exposure.

• Permeabilization: 0.1–0.5% Triton X-100 / saponin; titrate to minimize background.
  Microscopy and image analysis primers: University of Michigan, Colorado State University (.edu).

 Immunoprecipitation (IP) / Co-IP

• Lysis: mild, non-denaturing buffers preserve interacting factors in BER assemblies.

• Beads: protein A/G; preclear lysate; include DNase-free conditions if DNA bridging is a concern.
  Good practice notes: University of Wisconsin (.edu).

 ELISA (antigen or antibody capture)

• Coat with recombinant UNG or capture anti-UDG; block with BSA/casein; adopt 4PL curve-fitting and QC metrics per AGM (Assay Guidance Manual, nih.gov).
  Measurement assurance principles: NIST (.gov).

 ChIP / RIP-adjacent assays (method development)

• Although UDG is not DNA-binding per se, ChIP-style workflows may be adapted to study recruitment via protein partners; crosslinking and sonication parameters should be benchmarked against academic methods: Cornell, Oregon State University (.edu).

 PCR Carryover Prevention (dUTP–UDG system)

• Principle: incorporate dUTP in amplicons; pre-PCR UDG digestion removes carryover uracil-containing DNA; inactivation at 95 °C prevents template loss.

• Quality and contamination-control primers: CDC lab guidance (.gov); general PCR primers: UCSC Genome Browser resources and NLM Bookshelf (.edu/.gov).

Validation Framework (RUO)

Follow an explicit plan for specificity, sensitivity, precision, and robustness:

• Specificity: confirm loss of signal in UNG-depleted cells and absence of off-target detection of SMUG1/TDG/MBD4. Domain alignments via CDD guide cross-reactivity assessment (CDD, nih.gov).

• Sensitivity: determine minimal lysate load (WB) and minimal cell number (IF).

• Precision: intra-assay and inter-assay %CV with predefined acceptance criteria; fit with weighted 4PL/5PL for ELISA (AGM, nih.gov).

• Robustness: vary fixation, permeabilization, salt/detergent composition, incubation times/temps.

• Calibration / traceability: use mass/amount-traceable standards and instrument checks per NIST (NIST, .gov).

Representative Procedures

 Western Blot (example)

1. Prepare lysates (RIPA or nuclear fraction).

2. 10–12% SDS-PAGE; transfer to PVDF.

3. Block (5% BSA); primary anti-UDG 1–2 h RT or overnight 4 °C.

4. HRP-conjugated secondary; ECL detection; include UNG-KD negative control.
   Transfer and blotting primers: Harvard, Berkeley (.edu).

 Immunofluorescence

1. Seed cells on coverslips; fix 4% PFA 10 min.

2. Permeabilize 0.2% Triton X-100 5 min; block 1% BSA.

3. Primary anti-UDG (1:200–1:800) 1 h; secondary fluorophore 45 min.

4. Mount with antifade + DAPI; image with constant exposure settings.
   Microscopy basics: UCSF, UCLA (.edu).

 ELISA (antigen-capture)

1. Coat 96-well plate with recombinant UNG (0.5–2 µg/mL).

2. Block; add serially diluted anti-UDG.

3. Detect with anti-IgG-HRP; TMB develop; stop; read 450 nm with reference 570–620 nm.

4. Analyze with 4PL; verify residuals and back-calculated %RE within acceptance.
   Curve-fitting guidance: Assay Guidance Manual (nih.gov); instrument linearity: NIST (.gov).

Controls and Reference Materials

• Biological controls: UNG knockdown/knockout lines, rescue with siRNA-resistant UNG.

• Peptide blocking: pre-incubate antibody with immunogen peptide to confirm epitope specificity.

• Orthogonal assays: glycosylase activity readout on uracil-containing oligos.
  General control design references: NLM Bookshelf (nih.gov), academic method hubs MIT, Stanford (.edu).

Cross-Reactivity & Family Members

Human uracil glycosylases include UNG (UDG), SMUG1, TDG, and MBD4. Align immunogen sequences against these proteins to predict cross-reactivity; use CDD and RefSeq for curated sequences and domain boundaries:

• Structural/domain context: NCBI CDD (nih.gov)

• Family records & isoforms: RefSeq (nih.gov)

Data Integrity, Statistics, and Reporting

• Replication: technical (≥3) and biological (≥3) replicates.

• Analysis: weighted 4PL/5PL for binding/ELISA; report LOD/LOQ from blank + k·σ; maintain residual plots.

• Documentation: retain raw images, instrument IDs, software versions, and plate maps.
  Rigor & reproducibility frameworks: NIH Rigor & Reproducibility (.gov), data stewardship: NLM (.gov).

Storage, Handling, and Safety

• Storage: aliquot at −20 °C or 2–8 °C per formulation; avoid repeated freeze–thaw cycles.

• Working dilution: prepare fresh in filtered buffer with protein carrier to reduce nonspecific adsorption.

• Lab safety: follow standard chemical/biological handling SOPs.
  Safety references: CDC Laboratory (.gov), OSHA Laboratory Safety (.gov).

Troubleshooting Matrix

Academic troubleshooting primers: Harvard, Berkeley, UCSF, UCLA (.edu).

SEO Implementation Notes (Non-promotional, RUO)

Include exact phrases: “anti-UDG antibody,” “anti-UNG antibody,” “uracil-DNA glycosylase antibody,” “base excision repair antibody,” “UDG Western blot,” “UDG immunofluorescence,” “dUTP-UNG PCR system,” “DNA repair glycosylase ELISA,” “RUO.”
Use H1/H2 structure, descriptive figure alt-text (e.g., “UDG Western blot in nuclear extracts”), and internal links to related BER and PCR contamination-control topics. Avoid clinical/diagnostic claims.

Curated .edu / .gov Links (≥20 included above; consolidated list)

1. UNG gene: NCBI Gene (nih.gov)

2. RefSeq portal: RefSeq (nih.gov)

3. NCBI Protein: Protein (nih.gov)

4. Conserved domains: NCBI CDD (nih.gov)

5. NLM Bookshelf: Bookshelf (nih.gov)

6. Assay Guidance Manual: AGM (nih.gov)

7. UCSC Genome Browser: UCSC (.edu)

8. NIST Measurement resources: NIST (.gov)

9. CDC Laboratory guidance: CDC Labs (.gov)

10. OSHA Lab safety: OSHA

Example Specification Snippet (editable for your catalog)

• Target: Human UDG/UNG (base excision repair glycosylase)

• Host/Clone: (specify)

• Reactivity: human; cross-species predicted by sequence identity

• Applications: WB, IF/ICC, IP, ELISA; method-development for ChIP-style recruitment studies

• Validation: knockdown/knockout controls, peptide-blocking, orthogonal glycosylase activity assay

• Recommended dilutions: WB 1:1,000–1:5,000; IF 1:200–1:800; ELISA 0.1–1 µg/mL (optimize)

• Buffer: PBS/TBS with protein carrier and preservative (if applicable)

• Storage: aliquot; avoid freeze–thaw; RUO